Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Strana 1 z 74 Výsledek
Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and EGFR inhibitor
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
CROSS REFERENCE TO RELATED APPLICATION
The present application is a 35 U.S.C. .sctn.371 National Phase Entry Application from PCT/JP2012/062423, filed May 15, 2012, designating the United States, which in turn claims priority to Japanese Patent Application No. 2011-109599, filed on May 16, 2011,
Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Throughout the application various publications are referenced in parentheses. The disclosures of these publications in their entireties are hereby incorporated by reference in the application in order to more fully describe the state of the art to which this invention
Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
SCOPE OF THE INVENTION
This invention refers to a pharmaceutical composition that comprises the 2,5-dihydroxybenzenesulfonic acid, and its employment in the preparation of a medicine for treatment of diseases characterized by an intense cell proliferation, vascularization (angiodependent diseases)
Methods for cancer detection
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
The present invention relates to methods for early detection of cancer, and for monitoring progression, metastasis, and/or treatment efficacy of cancer. In particular, the invention provides a method for detection of cancer comprising detection of analytes indicative of cancer or a
Targeted osmotic lysis of cancer cells
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
TECHNICAL FIELD
This invention pertains to a method to target cancer cells that over-express voltage-gated sodium channels (VGSCs or "sodium channels") and to cause osmotic lysis of these cancer cells by initially inhibiting the sodium, potassium-adenosine triphosphatase (Na.sup.+, K.sup.+-ATPase or
Potassium ion channel blockers
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
This invention relates to compounds which have the ability to block potassium ion channels. In particular, the invention relates to sulphonylurea, sulphonylthiourea and sulphonylguanidine compounds which act to block potassium ion channels regulated by intracellular concentrations of adenosine
Thieno[3,2-c]pyridine potassium channel inhibitors
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to thienopyridine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment or prevention of cancer, arrhythmias, autoimmune diseases and
Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (K.sub.Ca)
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Throughout the application various publications are referenced in parentheses. The disclosures of these publications in their entireties are hereby incorporated by reference in the application in order to more fully describe the state of the art to which this invention
Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE DISCLOSURE
Compositions and methods are disclosed for treatment of numerous cancers with a halopyruvate. As such, the present invention involves the fields of chemistry, pharmacology, and biology.
BACKGROUND OF THE DISCLOSURE
Perhaps no other word or diagnosis strikes as much fear into
Method of treating cancer cells in humans
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
SUMMARY OF THE INVENTION
This invention relates to a method of treating or inhibiting cancer cells in the pancreas, liver, kidney, lymph glands, salivary glands, breast, lung and stomach of humans, by administration of an alkali metal or alkaline earth metal salt of 5,6-O-benzylidene-L-ascorbic
Treatment for cancer and compounds for use therewith
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention relates to cancer treatment. More particularly, it relates to a method for treating and curing cancer, and to compounds for use in the treatment. The present invention provides a totally new and unique approach to the identification of the primary
Alkaline salt solutions for treating cancerous tumors
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
This invention is in the field of pharmacology, and relates to drugs that are useful for treating cancerous tumors.
The cellular physiology and genetic basis of cancerous tumors are well-known and are discussed in numerous reference works, including DeVita et al 1993,
Bisarylamines as potassium channel openers
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
This invention relates to the use of certain bisarylamines as potassium channel openers and to the treatment of diseases modulated by potassium channel opening. Additionally, this invention relates to novel compounds that are useful as potassium channel openers.
BACKGROUND OF
Heterocycles as potassium channel modulators
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
Heterocycles as potassium channel modulators
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
Nejúplnější databáze léčivých bylin podložená vědou
- Funguje v 55 jazycích
- Bylinné léky podporované vědou
- Rozpoznávání bylin podle obrázku
- Interaktivní mapa GPS - označte byliny na místě (již brzy)
- Přečtěte si vědecké publikace související s vaším hledáním
- Hledejte léčivé byliny podle jejich účinků
- Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty
Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu
